scholarly journals Local control of human papillomavirus infection after anal condylomata acuminata eradication

2014 ◽  
Vol 41 (2) ◽  
pp. 87-91 ◽  
Author(s):  
Thiago da Silveira Manzione ◽  
Sidney Roberto Nadal ◽  
Edenilson Eduardo Calore ◽  
Luís Roberto Manzione Nadal ◽  
Carmen Ruth Manzione

OBJECTIVE: To verify whether the eradication of anal condylomata acuminata was effective for local control of HPV infection using anal colposcopy and anal brush cytology.METHODS: We evaluated 147 patients treated for anal margin and/or anal canal condyloma, with 108 HIV-positive and 39 HIV-negative individuals. The average age for males was 40 years for HIV-positive and 27.5 for HIV-negative. In females, the mean age was 37.5 years for HIV-positive and 31.5 for HIV-negative.RESULTS: Twenty-four patients (16.3%) had normal cytology and anal colposcopy, 16 (10.9%) normal cytology and altered anal colposcopy, 52 (35.4%) normal anal colposcopy and altered cytology, and 55 (37.4%) had altered cytology and anal colposcopy.CONCLUSION: the eradication of clinical lesions failed to locally control HPV infection.

2015 ◽  
Vol 212 (5) ◽  
pp. 760-768 ◽  
Author(s):  
Katia Muller ◽  
Julie Kazimiroff ◽  
Mahnaz Fatahzadeh ◽  
Richard V. Smith ◽  
Mauricio Wiltz ◽  
...  

2012 ◽  
Vol 17 (4) ◽  
pp. 9-11
Author(s):  
E. S Sverdlova ◽  
T. V Dianova

As participation of immune system in the protection of human papillomavirus (HPV) has been proven, the incidence of HPV infection leading to cervical intraepithelial neoplasia (CIN) among HIV-positive women is 4 times higher than in HIV-negative cases. In the presence of HIV HPV implements oncoprogram during 6-12 months. Сytokine imbalance makes a significant contribution to the progression of HIV in combination with HPV. The criteria of selection of patients with HIV for therapy cytokines in CIN 2-3 (Roncoleukin used in the author's scheme). Using Ronkoleukin in combination with HAART in HIV-positive women can delay the progression of CIN 2-3 in cervical cancer. The criteria of selection of HIV female patients for the therapy with cytokines at the 2-3 stage of CIN ( Roncoleukin was used in the author's scheme) have been detected. Application Roncoleukin in combination with HAART in HIV-positive women can delay the progression of cervical cancer at the CIN 2-3 stage.


PLoS ONE ◽  
2015 ◽  
Vol 10 (11) ◽  
pp. e0143698 ◽  
Author(s):  
Hilary A. Robbins ◽  
Christina E. Fennell ◽  
Maura Gillison ◽  
Weihong Xiao ◽  
Yingshi Guo ◽  
...  

2015 ◽  
Vol 39 (6) ◽  
pp. 917-922 ◽  
Author(s):  
Piamkamon Vacharotayangul ◽  
Sorasun Rungsiyanont ◽  
Aroonwan Lam-ubol ◽  
Tippawan Pankam ◽  
Piyanee Rodbamrung ◽  
...  

Author(s):  
Joel Palefsky ◽  
Howard Minkoff ◽  
Leslie A. Kalish ◽  
Alexandra Levine ◽  
Henry Sacks ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document